AI assistant
Sending…
CVS GROUP PLC — Major Shareholding Notification 2014
Feb 7, 2014
7590_mrq_2014-02-07_5bdc2022-bd5d-4e59-aa37-0df3825d25c0.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6176Z
CVS Group plc
07 February 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | CVS GROUP PLC |
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||
| An acquisition or disposal of voting rights | YES | |
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||
| An event changing the breakdown of voting rights | ||
| Other (please specify): | ||
| 3. Full name of person(s) subject to the notification obligation: iii | Harwood Capital LLP (as Investment Adviser/Manager) |
| 4. Full name of shareholder(s) (if different from 3.): iv |
Holder 1. Oryx International Growth Fund Limited Holder 2. North Atlantic Smaller Companies Investment Trust Plc |
| 5. Date of the transaction and date on which the threshold is crossed or reached: v | 6th February 2014 |
| 6. Date on which issuer notified: | 7th February 2014 |
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
Total holding below 3% |
| 8. Notified details: | |||||||
| A: Voting rights attached to shares viii, ix | |||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | |||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | |||
| Direct | Direct xi | Indirect xii | Direct | Indirect | |||
| Ordinary Shares Sedol: B286382 Holder 1 Holder 2 |
597,000 1,198,000 |
597,000 1,198,000 |
550,000 1,100,000 |
550,000 1,100,000 |
0.95% 1.89% |
| B: Qualifying Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
| Resulting situation after the triggering transaction | ||||||
| Type of financial instrument |
Exercise price |
Expiration date xvii |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to |
% of voting rights xix, xx | |
| Nominal | Delta | |||||
| Total (A+B+C) | |
| Number of voting rights | Percentage of voting rights |
| 1,650,000 | 2.84% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
| Proxy Voting: | |
| 10. Name of the proxy holder: | |
| 11. Number of voting rights proxy holder will cease to hold: | |
| 12. Date on which proxy holder will cease to hold voting rights: |
| 13. Additional information: | Harwood Capital LLP is the investment adviser/manager in respect of the full 4.94% holding. |
| 14. Contact name: | Bonita Guntrip |
| 15. Contact telephone number: | 020 7640 3203 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFEEFRIDIIS
More from CVS GROUP PLC
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 21
Major Shareholding Notification
2026
Apr 20
Declaration of Voting Results & Voting Rights Announcements
2026
Mar 31
Board/Management Information
2026
Mar 30
Board/Management Information
2026
Mar 25
Legal Proceedings Report
2026
Mar 24
Share Issue/Capital Change
2026
Feb 27
Interim / Quarterly Report
2026
Feb 26